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multiple myelomaTRAF3, a critical regulator of B cell survival, was recently recognized as a tumor suppressor gene in B lympho-
cytes. Speciﬁc deletion of TRAF3 from B lymphocytes leads to spontaneous development of marginal zone lym-
phomas (MZL) or B1 lymphomas in mice. To identify novel oncogenes and tumor suppressive genes involved
inmalignant transformation of TRAF3-deﬁcient B cells, we performed amicroarray analysis to identify genes dif-
ferentially expressed in TRAF3−/−mouse splenic B lymphomas. We have identiﬁed 160 up-regulated genes and
244 down-regulated genes in TRAF3−/−B lymphomas as compared to littermate control splenocytes. Here we
describe the samples, quality control assessment, as well as the data analysis methods in detail for the
transcriptomic proﬁling study. Data are archived at NIH GEO with accession number GSE48818.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).SpeciﬁcationsOrganism/cell line/tissue Mus musculus
Sex Male and female
Sequencer or array type Illumina Sentrix MouseRef-8 24 K
Data format Raw and processed
Experimental factors TRAF3-deﬁcient splenic B lymphomas and
littermate control splenocytes
Experimental features Microarray data of TRAF3-deﬁcient splenic B
lymphomas and littermate control splenocytes
Consent Not applicable
Sample source location Piscataway, New Jersey, USADirect link to deposited data
Deposited data can be found at http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE48818.gy and Neuroscience, Rutgers
Piscataway, NJ 08854, United
. This is an open access article underExperimental design, materials, and methods
Sample collection and preparation
Spleens were harvested from B cell-speciﬁc TRAF3-deﬁcient mice
with B lymphomas or tumor-free littermate control mice (Table 1). In
the three selected TRAF3−/− splenic B lymphoma samples (mouse ID:
6983-2, 7041-10, and 7060-8), B lymphoma cells are N70% of B cells
as assessed by FACS analysis of B cell populations and Southern blot
analysis of IgH gene rearrangements [1]. Spleens were separated into
single cell suspensions by mechanic dissociation, and red blood cells
were depleted using 1X ACK solution as described [2,3]. The resulting
splenocytes were collected for total cellular RNA extraction using TRIzol
reagent (Invitrogen, Carlsbad, CA) following themanufacturer's instruc-
tions. RNA sampleswere puriﬁed using an RNeasyMinElute Cleanup Kit
(QIAGEN, Valencia, CA). RNA concentration and quality were assessed
using a NanoDrop spectrometer (NanoDrop Products, Wilmington,
DE) (Table 1). RNA integrity was further analyzed on an RNA Nano
Chip using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo
Alto, CA), and the results are shown in Fig. 1.Gene expression analysis
The mRNA was ampliﬁed with a TotalPrep RNA ampliﬁcation kit
with a T7-oligo(dT) primer according to themanufacturer's instructionsthe CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Table 1
RNA samples for transcriptome proﬁling by microarray analysis.
Sample ID Sample Name Mouse ID Genotype Tissue Concentraction O.D. 260/280 O.D. 260/230 Total volume
GSM1185225 XP1 6983-2 TRAF3ﬂox/ﬂox, CD19+/Cre Spleen 200 ng/μl 2.09 2.01 5 μl
GSM1185226 XP2 7041-10 TRAF3ﬂox/ﬂox, CD19+/Cre Spleen 100 ng/μl 2.08 2.08 10 μl
GSM1185227 XP3 7060-8 TRAF3ﬂox/ﬂox, CD19+/Cre Spleen 200 ng/μl 2.09 1.83 5 μl
GSM1185228 XP5 6983-6 TRAF3ﬂox/ﬂox Spleen 100 ng/μl 2.09 2.09 10 μl
GSM1185229 XP6 7060-5 TRAF3ﬂox/ﬂox Spleen 200 ng/μl 2.07 2.39 5 μl
GSM1185230 XP7 7060-6 TRAF3ﬂox/ﬂox Spleen 200 ng/μl 2.03 2.16 5 μl
GSM1185231 XP9 7041-9 TRAF3ﬂox/ﬂox Spleen 200 ng/μl 2.08 2.01 5 μl
A
B
RIN: 8.60 RIN: 7.80
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Fig. 1.Quality control assay of RNAs used for microarrays. (A) Bioanalyzer output as gel images for all seven samples as identiﬁed by theMouse ID (see Table 1). (B) Bioanalyzer output as
traces with RIN (RNA integrity number) shown for each sample. Results are plotted as ﬂuorescence units [FU] over time [s].
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Fig. 2. Volcano plot of limma-modeled microarray data. The data for all genes are plotted as log2 fold change versus the−log10 of the adjusted p-value. Thresholds are shown as dashed
lines. Genes selected as signiﬁcantly different are highlighted as blue dots. The top ten genes (sortedby adjusted p-value) are labeledwith gene symbols. Note theprominent position of the
MCC gene, which was chosen for further analysis [8].
388 P. Xie et al. / Genomics Data 2 (2014) 386–388(Ambion), and microarray analysis was carried out with the Illumina
Sentrix MouseRef-8 24K Array at the Burnham Institute (La Jolla, CA).
Data processing and normalization
Results were extracted with Illumina GenomeStudio v2011.1 and
exported as the sample probe proﬁle formatwithout background correc-
tion or normalization. This ﬁle, along with a matching control table out-
put fromGenomeStudio, was loaded into a lumi object in R/Bioconductor
[4–6]. Gene probes were tracked using the nuID system [4]. Background
correction and quantile normalization was performed using the
lumiExpresso function. Expression data above detection limits (using
the detectionCall function) were selected for modeling. Target data
were used to extract RNA group names as factors and assembled into a
model matrix. Extracted expression values, the model design, and the
array weights were used to model data in the limma package [7]. The
contrast of “B lymphoma—control” was selected and used to generate
contrasts using the eBayes function. Finally, gene annotation was added
using the lumiMouseAll.db and annotate packages. Results were selected
using the topTable function (with n = Inf to output all contrasts) and
saved as in csv format. This table was reviewed using Excel to select sig-
niﬁcantly different genes with a minimum mean fold change (Supple-
mental Table 1). A volcano plot of the modeled data clearly shows
large numbers of signiﬁcantly different genes with an adjusted p-value
≤0.05 and a log2 fold change ≥1 (Fig. 2).
Microarray data are available from NIH GEO Accession GSE48818
and described by Edwards et al. [8].
Statistics
Statistical analyses were performed using limmamodeling (ANOVA
with empirical Bayesmoderation of standard errors). Adjusted p-values
less than 0.05 with a fold-change greater than 2 are considered
signiﬁcant.Discussion
Results of the microarray analysis have identiﬁed 160 up-regulated
genes and 244 down-regulated genes in TRAF3−/− B lymphomas as
compared to LMC spleens (2-fold up or down fold-change, adjusted
p b 0.05) (NCBI GEO accession number: GSE48818).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gdata.2014.10.017.
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